Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rela Institute of Liver Disease & Transplantation (RILDT), part of Dr. Rela Institute & Medical Centre in Chennai, India, is a premier, highly specialized healthcare facility dedicated to the treatment of liver and hepatopancreatobiliary (HPB) diseases. Founded by world-renowned liver transplant surgeon Prof. Mohamed Rela, the institute is recognized as one of the largest and most advanced liver transplantation centers globally, particularly noted for its pioneering work in pediatric liver transplantation. RILDT offers a comprehensive, multidisciplinary approach to liver care, utilizing state-of-the-art technologies such as robotic-assisted surgery and advanced liver intensive care. The center serves both domestic and international patients, performing hundreds of successful adult and pediatric liver transplants annually with exceptional survival rates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institute of liver disease and transplantation.